Spravato vs IV Ketamine: Precision, Control, and the Design of Modern Psychiatric Care

When SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements. was approved, it marked something significant. For decades, psychiatry moved slowly: incremental adjustments, modest gains, long waiting periods. Then ketamine research began demonstrating rapid antidepressantA medication that alters brain chemistry to relieve depression. effects in treatment-resistant patients. That momentum could not be ignored.

SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements. represents the healthcare system’s attempt to integrate that discovery into a regulated framework. It is structured, FDA-approved, and distributed under a Risk Evaluation and Mitigation Strategy (REMS). In many ways, it is a bridge - an effort to make a powerful intervention accessible within traditional guardrails.¹

That intention deserves acknowledgment. But approval does not eliminate complexity. It clarifies one model of implementation. The deeper question remains:

How should powerful psychiatric treatments be delivered?

Understanding Spravato and IV Ketamine Therapy

Both SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements. (intranasal esketamine) and IV ketamine act on glutamatergic systems involved in mood regulation and synaptic plasticity.² Both are used in treatment-resistant depressionDepression that persists despite adequate trials of antidepressant treatment..

Where they diverge is not molecular philosophy, it is in delivery architecture.

SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements. is administered intranasally in a supervised setting. Absorption occurs through nasal mucosa. Dosing follows fixed increments. Monitoring is structured around observation periods.

IV ketamine is delivered directly into the bloodstream under continuous physician control. Dose and infusion rate can be adjusted in real time. Plasma exposure is predictable. The treatment can be modulated as it unfolds.

These are not minor differences. They reflect two philosophies: standardized distribution versus dynamic clinical control.

Why Was Spravato Released?

SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements. emerged because psychiatry needed a regulated framework.

Racemic IV ketamine, though supported by substantial academic research, remains an off-label treatment. Regulatory systems, insurers, and large healthcare infrastructures require standardized approval pathways.

An FDA-approved intranasal formulation provided:

• Defined distribution controls
• Insurance compatibility
• REMS oversight
• Structured dosing schedules

In this sense, SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements. expanded access. Access matters. But accessibility and personalization are not identical goals.

As the field evolves, these questions about delivery and precision have become increasingly important.

This article is part of Fountain Health’s exploration of how ketamine therapy is evolving in modern psychiatric care.

Ketamine Delivery: Standardized Pathway vs Physician-Controlled Precision

Ketamine is not a mild intervention. It alters perception, mood circuitry, and neuroplastic signaling. When consciousness shifts, even therapeutically, environment matters.

A physician-controlled IV setting allows:

• Adjustment of infusion rate during the session
• Modulation of intensity in response to presentation
• Session-by-session recalibration
• Continuous physiological monitoring

Intranasal administration follows fixed dosing increments and introduces variability in mucosal absorption, which differs between individual patients.

Neither model is inherently irresponsible, but greater control permits greater adaptability. And adaptability is not only important in severe cases. It is beneficial whenever nuance exists, which in psychiatry, is almost always.

That is precisely why Fountain Health’s IV ketamine approach is widely acknowledged as deeply personalized. Treatment is adjusted to the individual’s neurobiology, symptom pattern, and response trajectory; not confined to preset increments. Precision is not an upgrade layered onto care. It is the structure of the care itself.

Mental Health Is Biological

At Fountain Health, we operate from a foundational principle: Mental health is biological. (Read more.) DepressionA prolonged low mood that interferes with life. is not a moral failing. AnxietyA state of worry or tension that disrupts focus and sleep. is not a character flaw. Treatment resistance is not a lack of effort. They reflect dysregulation in neural circuitry, often involving glutamateA glutamate receptor involved in synaptic signaling, learning, and memory. signaling, stressThe body's response to external demands. Chronic stress disrupts hormones, sleep, and immune function.-response pathways, and impaired synaptic connectivity.

Ketamine’s rapid antidepressantA medication that alters brain chemistry to relieve depression. effects are believed to arise from modulation of NMDA receptorsA glutamate receptor involved in synaptic signaling, learning, and memory. and downstream synaptogenesisThe formation of synapses between neurons.. This biological mechanism is powerful. And like any powerful intervention acting on the brain, it deserves precision.

When we treat depressionA prolonged low mood that interferes with life. biologically, we must also deliver care biologically; with measured dosing, monitoring, and adaptation.

The Philosophy of Precision

Modern healthcare often favors scalability: standardized protocols expand access, fixed dosing simplifies distribution, uniform processes improve efficiency. Efficiency, however, is not the same as personalization.

Throughout medicine, powerful agents are administered within structured clinician-led settings. Anesthetics. Chemotherapy. Biologic infusions. Not because patients are incapable, but because potency warrants oversight.

Ketamine is no exception. Even outside severe psychiatric presentations, a controlled environment offers:

• Reduced variability
• Reduced misuse risk
• Greater adaptability
• Enhanced therapeutic containment

Control is not about restriction. It is about care. In treatment-resistant depressionDepression that persists despite adequate trials of antidepressant treatment., especially when layered with anxietyA state of worry or tension that disrupts focus and sleep., traumaA deeply distressing experience that leaves lasting psychological impact. history, or substance vulnerability, small adjustments influence durability. IV infusion allows those adjustments to happen in real time. That is not a rejection of regulation. It is an affirmation of physician stewardship.

Responsibility Beyond Approval

Ketamine carries documented abuse potential outside structured medical environments.⁴ That reality is reflected in federal prescribing frameworks and addictionA condition where the brain's reward system drives compulsive use of a substance or behavior, despite harm. medicine literature.

SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements.’s REMS program acknowledges that potency requires boundaries. But boundaries can exist at varying levels of control.

Continuous physician oversight during IV infusion reduces variability further. It centralizes responsibility and eliminates self-administration dynamics.

In our NYC practice, this level of control is not reserved for high-risk individuals. It is simply the standard applied to powerful neuropsychiatric treatments. Because powerful tools deserve careful hands.

Take a free Ketamine Therapy assessment

From Delivery Method to Treatment Design

The difference between SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements. and IV ketamine ultimately reflects a broader philosophical distinction: Standardization versus dynamic clinical discretion.

At Fountain Health, IV delivery is only one component of a broader proprietary protocol integrating:

• Structured psychiatric assessment
• Addiction-aware screening
• Neuroplasticity timing optimization
• Individualized maintenance recalibration

(For deeper insight, read our white paper: The Fountain Health 4-Phase Ketamine Therapy framework)

Ketamine is not a session. It is a system that begins before the treatment and continues well beyond the infusions themselves. SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements. expanded accessibility. Physician-controlled IV ketamine preserves adaptability.

The evolution of psychiatric care will depend not only on innovation, but on how carefully we design the environment in which powerful treatments are delivered. In practice, this means designing care around the patient rather than the product.

Stewardship defines the standard.

Book a Free Consultation

Continue exploring ketamine therapy

• Treating Depression and Anxiety Together with Ketamine
• SpravatoAn FDA-approved esketamine nasal spray with specific labeled indications and safety requirements. vs IV Ketamine: Precision and Delivery
• Why Ketamine Treatment Sometimes Fails

References

1. U.S. Food and Drug Administration. Spravato (esketamine) Nasal Spray Prescribing Information and REMS Program. FDA; 2019.

2. Duman RS, Aghajanian GK. Synaptic dysfunction in depressionA prolonged low mood that interferes with life.: potential therapeutic targets. Science. 2012;338(6103):68–72.

3. Zarate CA Jr, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depressionA prolonged low mood that interferes with life.. Archives of General Psychiatry. 2006;63(8):856-864.

4. National Institute on Drug Abuse (NIDA). Ketamine DrugFacts. National Institutes of Health.

###

About Fountain: Fountain Health NYC is the next-generation integrative mental health and medical wellness center exploring the frontier between neuroscience, technology, and human consciousness; redefining what healing can look like in the 21st century.